We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

6 hedge funds and large institutions have $13 invested in Ampio Pharmaceuticals Inc. in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% less funds holding

Funds holding: 286 (-22)

88% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 25

100% less capital invested

Capital invested by funds: $34.2K → $13 (-$34.2K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
-22
Holders Change %
-78.57%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
1
Closed
25
Calls
Puts
Net Calls
Net Calls Change

AMPE Hedge Fund Activity: Q2 2024 in Review

6 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2024, worth a combined $13 — down 100% from $34.2K a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of AMPE and 3 opened new positions — a net loss of 22 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Carson Wealth (CWM LLC), opening a new position worth an estimated $6. The largest seller was Virtu Financial, exiting entirely with an estimated $18K sold.

  • 6 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2024, down from 28 in Q1 2024.
  • Funds reported $13 of Ampio Pharmaceuticals Inc. stock for Q2 2024, down 100% quarter-over-quarter.
  • 3 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2024 and 25 closed out, a net change of -22 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2024 was Carson Wealth (CWM LLC), an estimated $6 added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2024 was Virtu Financial, an estimated $18K sold.

Based on aggregated 13F filings for Q2 2024.